NCT00835718终止2 期
A Phase II Multicenter, Randomized, Double-Blind, Two-Stage Clinical Trial to Evaluate the Efficacy and Safety of MK0594 in Patients With Alcohol Dependence
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 入组人数
- 162
- 主要终点
- no heavy alcohol drinking and safety as measured by adverse experiences, laboratory safety test, vital signs, ECG, and physical examination
研究概览
简要总结
A study in patients with alcohol dependence to see if MK0594 is safe and effective in maintaining absence of heavy drinking over a 12-week treatment period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient has Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision diagnosis of alcohol dependence and alcohol addiction
- •Patient has two heavy drinking days in the last 30 days
- •Patient has 3 days of abstinence from alcohol right before taking study medication
- •Patient has lived in the same residence for the last 2 months
排除标准
- •If female, patient is pregnant or breastfeeding
- •Patient anticipated inpatient alcohol treatment
- •Patient has a history of suicide attempt in the last year
- •Patient has schizophrenia or bipolar disorder
- •Patient has a history of multiple or serious allergies
- •Patient has participated in a clinical trial in the last 30 days
结局指标
主要结局
no heavy alcohol drinking and safety as measured by adverse experiences, laboratory safety test, vital signs, ECG, and physical examination
时间窗: week 3 and 12 after starting study medication for efficacy and over 12 weeks and 52 weeks for safety
no heavy alcohol drinking and safety as measured by adverse experiences, laboratory safety test, vital signs, ECG, and physical examination
次要结局
- no alcohol drinking(week 3 to 12 after starting study medication and over 52 weeks)
研究者
相似试验
已完成
2 期
A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)NCT06685692Aldeyra Therapeutics, Inc.4
尚未招募
2 期
A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use DisorderAlcohol AbuseAlcohol Abuse/addictionPain ThresholdDepression DisordersSleep DisorderAnxietyNCT06710431Afasci Inc36
招募中
2 期
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver DiseaseLiver Diseases, AlcoholicNCT06613698GlaxoSmithKline393
已完成
2 期
A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831Non-Alcoholic SteatohepatitisNCT00668070Astellas Pharma Inc114
撤回
1 期
Effects of GSK598809 on Brain Activation in Abstinent AlcoholicsSubstance DependenceAlcohol DependenceNCT00908206GlaxoSmithKline